The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2,717.9 million in 2023 and is expected to reach US$ 5,264.4 million by 2033.
The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing number of trauma and injury cases.
Apheresis is a procedure wherein blood is withdrawn from a donor’s body, extraction of one or more blood components such as platelets, plasma, and white blood cells, and transfusing of the remaining blood back into the donor during the procedure or at the end of it. Therapeutic apheresis is a process of removing blood components from a patient with apheresis technology.
Therapeutic apheresis is used for removing defective cells. It is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity.
Basically, there are three types of therapeutic apheresis procedures used, namely therapeutic plasma exchange (TPE), red blood cell exchange (RBCX), and cellular depletion. Therapeutic plasma exchange is the elimination of a huge volume of plasma from the patient and replacing the plasma with suitable fluids. TPE is commonly used for the treatment of autoimmune diseases or immune-mediated diseases or disorders.
TPE removes paraproteins, monoclonal antibiotics, antigen-antibody, and autoimmune antibody complexes. Therapeutic apheresis particularly removes the significant proportion of one or more components causing diseases.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Attributes | Value |
|---|---|
| Therapeutic Apheresis Market Size (2023) | US$ 2,717.9 million |
| Therapeutic Apheresis Market Projected Size (2033) | US$ 5,264.4 million |
| Therapeutic Apheresis Market CAGR (2023 to 2033) | 6.8% |
Rental model’s installation of apheresis devices, strict donor recruitment criteria, and decreased blood donations using apheresis as a result of lack of awareness are likely to restrict the market further over the forecast period.
Principal Consultant
| Countries | Market Share (2022) |
|---|---|
| United States | 28.8% |
| Germany | 6.3% |
| Japan | 4.2% |
North America accounted for the leading share, i.e. 32.6% market share in 2022. Factors like growing demand for plasma-derived medicines production and well-established healthcare infrastructure. This region has smooth accessibility to advanced blood collection technologies. It also has the presence of some of the significant apheresis companies in the region.
Additionally, reasons such as soaring initiatives by the government towards blood donation coupled with the rising need for blood components across the globe. Moreover, approval of the latest indications for apheresis treatment, such as acute disseminated encephalomyelitis, autoimmune haemolytic anemia, and neonatal cardiac lupus, support the growth of the market in this region.
In 2022, Europe accounted for 29.8% market share in the global market, owing to the growing prevalence of blood disorders such as profuse bleeding and a decrease in platelet count.
This region witnessed increasing cases of chronic diseases such as autoimmune diseases and cancer, and a growing number of organ donors also is supporting the growth of the market in this region.
The escalation in the rate of occurrence of chronic diseases, growing necessity for plasma sources, additional activities considering blood safety, and an increasing number of complicated surgical procedures are also fuelling the Europe therapeutic apheresis sector.
In June 2022, BioCaptiva raised nearly US$ 2.6 million in the latest seed funding to additionally develop its BioCaptis instrument which is an apheresis-based cell-free DNA capture device for using liquid biopsy testing. The financial round was led by existing investor Archangels, who joined Scottish Enterprise, Cancer Research Horizons, and novel investor Old College Capital.
Key Players Benchmarking The Therapeutic Apheresis Industry
The market has an oligopolistic structure and is characterized by frequent mergers and acquisitions. Industry companies frequently employ new product development and strategic partnerships as sustainability strategies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Therapeutic Apheresis Market CAGR for 2033 is 5.2%.
The market is estimated to reach US$ 5,264.4 million by 2033.
Key market players in the Therapeutic Apheresis Market are Terumo BCT, Inc., Fresenius SE & Co. KGaA, and Haemonetics Corporation.
The market is estimated to secure a valuation of US$ 2,717.9 million in 2023.
The market for apheresis is being driven by an increase in chronic disorders. Personal apheresis is expanding with new technology and home use. Patient security is a top priority.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure Types
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Procedure Types, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure Types, 2023 to 2033
5.3.1. Therapeutic Plasma Exchange (TPE)
5.3.2. Red Blood Cell Exchange (RBCX)
5.3.3. Cellular Depletions
5.4. Y-o-Y Growth Trend Analysis By Procedure Types, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Procedure Types, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033
6.3.1. Centrifugation
6.3.2. Membrane filtration
6.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
7.3.1. Hematology
7.3.2. Neurology
7.3.3. Nephrology
7.3.4. Rheumatology
7.3.5. Oncology
7.3.6. Others
7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals
8.3.2. Blood Banks
8.3.3. Specialty Clinics
8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Procedure Types
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Procedure Types
10.3.3. By Technology
10.3.4. By Application
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Procedure Types
11.2.3. By Technology
11.2.4. By Application
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Procedure Types
11.3.3. By Technology
11.3.4. By Application
11.3.5. By End User
11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. UK
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Procedure Types
12.2.3. By Technology
12.2.4. By Application
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Procedure Types
12.3.3. By Technology
12.3.4. By Application
12.3.5. By End User
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Procedure Types
13.2.3. By Technology
13.2.4. By Application
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Procedure Types
13.3.3. By Technology
13.3.4. By Application
13.3.5. By End User
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Procedure Types
14.2.3. By Technology
14.2.4. By Application
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Procedure Types
14.3.3. By Technology
14.3.4. By Application
14.3.5. By End User
14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Procedure Types
15.2.3. By Technology
15.2.4. By Application
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Procedure Types
15.3.3. By Technology
15.3.4. By Application
15.3.5. By End User
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Procedure Types
16.2.3. By Technology
16.2.4. By Application
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Procedure Types
16.3.3. By Technology
16.3.4. By Application
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Procedure Types
17.1.2.2. By Technology
17.1.2.3. By Application
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Procedure Types
17.2.2.2. By Technology
17.2.2.3. By Application
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Procedure Types
17.3.2.2. By Technology
17.3.2.3. By Application
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Procedure Types
17.4.2.2. By Technology
17.4.2.3. By Application
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Procedure Types
17.5.2.2. By Technology
17.5.2.3. By Application
17.5.2.4. By End User
17.6. UK
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Procedure Types
17.6.2.2. By Technology
17.6.2.3. By Application
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Procedure Types
17.7.2.2. By Technology
17.7.2.3. By Application
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Procedure Types
17.8.2.2. By Technology
17.8.2.3. By Application
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Procedure Types
17.9.2.2. By Technology
17.9.2.3. By Application
17.9.2.4. By End User
17.10. Poland
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Procedure Types
17.10.2.2. By Technology
17.10.2.3. By Application
17.10.2.4. By End User
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Procedure Types
17.11.2.2. By Technology
17.11.2.3. By Application
17.11.2.4. By End User
17.12. Czech Republic
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Procedure Types
17.12.2.2. By Technology
17.12.2.3. By Application
17.12.2.4. By End User
17.13. Romania
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Procedure Types
17.13.2.2. By Technology
17.13.2.3. By Application
17.13.2.4. By End User
17.14. India
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Procedure Types
17.14.2.2. By Technology
17.14.2.3. By Application
17.14.2.4. By End User
17.15. Bangladesh
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Procedure Types
17.15.2.2. By Technology
17.15.2.3. By Application
17.15.2.4. By End User
17.16. Australia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Procedure Types
17.16.2.2. By Technology
17.16.2.3. By Application
17.16.2.4. By End User
17.17. New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Procedure Types
17.17.2.2. By Technology
17.17.2.3. By Application
17.17.2.4. By End User
17.18. China
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Procedure Types
17.18.2.2. By Technology
17.18.2.3. By Application
17.18.2.4. By End User
17.19. Japan
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Procedure Types
17.19.2.2. By Technology
17.19.2.3. By Application
17.19.2.4. By End User
17.20. South Korea
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Procedure Types
17.20.2.2. By Technology
17.20.2.3. By Application
17.20.2.4. By End User
17.21. GCC Countries
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Procedure Types
17.21.2.2. By Technology
17.21.2.3. By Application
17.21.2.4. By End User
17.22. South Africa
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2022
17.22.2.1. By Procedure Types
17.22.2.2. By Technology
17.22.2.3. By Application
17.22.2.4. By End User
17.23. Israel
17.23.1. Pricing Analysis
17.23.2. Market Share Analysis, 2022
17.23.2.1. By Procedure Types
17.23.2.2. By Technology
17.23.2.3. By Application
17.23.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Procedure Types
18.3.3. By Technology
18.3.4. By Application
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Asahi Kasei Medical Co.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Haemonetics Corporation
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Miltenyi Biotec
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Cerus Corporation
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Terumo BCT Inc.
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Fresenius Kabi USA
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Terumo Bct
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. B. Braun Melsungen AG
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Nikkiso Co. Ltd.
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. Medica S.p.A.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.11. Baxter Healthcare Corporation
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.12. Kawasumi Laboratories Inc.
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.13. Therakos Incorporation
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Therapeutic Apheresis Market
